Home > Keywords >
| Catalog | name | Description | price |
|---|---|---|---|
| R-C-1608 | DBPR-114 CAS:2443767-35-7 | BPR1K871 is a potent and selective dual FLT3/AURKA inhibitor with IC50s of 19 nM and 22 nM for FLT3 and AURKA,respectively,acts as a preclinical development candidate for anti-cancer therapy. | price> |
| R-R-3308 | 4F 4PP oxalate CAS No.144734-36-1 | 4F 4PP (oxalate)/CAS No.144734-36-1 is a selective 5-HT2A antagonist with almost as high affinity (Ki= 5.3 nM) as ketanserin but with a much lower affinity for 5-HT2C sites (Ki= 620 nM). | price> |
| R-C-1609 | ACY738 CAS:1375465-91-0 | ACY-738 is a potent,selective and orally-bioavailable HDAC6 inhibitor,with an IC50 of 1.7 nM;ACY-738 also inhibits HDAC1,HDAC2,and HDAC3,with IC50s of 94,128,and 218 nM. | price> |
| R-R-3309 | PNU-142633 CAS No.187665-65-2 | PNU-142633/CAS No.187665-65-2 is a high affinity, selective and orally active 5-HT1D receptor agonist with Kis of 6 nM and > 18 000 nM for human 5-HT1D receptor and human 5-HT1B receptor, respectively. PNU-142633 has anti-migraine efficacy. | price> |
| R-C-1610 | Abivertinib maleate CAS:1557268-88-8 | Abivertinib,also known as avitinib,AC0010 or AC0010MA,is an orally available, irreversible,epidermal growth factor receptor(EGFR)mutant-selective inhibitor, with potential antineoplastic activity.Upon oral administration,avitinib covalently binds to and inhibits the activity of mutant forms of EGFR,including the drug-resistant T790M EGFR mutant,which prevents signaling mediated by mutant forms of EGFR.This may both induce cell death and inhibit tumor growth in EGFR-mutated tumor cells.EGFR,a receptor tyrosine kinase that is mutated in a variety of cancers,plays a key role in tumor cell proliferation and tumor vascularization.As this agent is selective towards mutant forms of EGFR,its toxicity profile may be reduced when compared to non-selective EGFR inhibitors, which also inhibit wild-type EGFR. | price> |
| R-R-3310 | 5-HT1A modulator 1 CAS No.142477-34-7 | 5-HT1A modulator 1/CAS No.142477-34-7 displays very high affinities for the 5HT1A, adrenergic α1 and dopamine D2 receptor with IC50s of 2 ±0.3 nM, 10 ± 3 nM and 40 ±9 nM, respectively. | price> |
| R-C-1611 | SAR348830 CAS:1462949-64-9 | SAR348830 is novel potent and selective inhibitor of anaplastic lymphoma kinase (ALK). | price> |
| R-R-3311 | E-3620 CAS No.151213-86-4 | E-3620/CAS No.151213-86-4 is a potent 5-HT3 receptor antagonist. E-3620 can be used for the research of dyskinesi and gastrointestinal motility. | price> |
| R-C-1612 | CXD101 CAS: 934828-12-3 | CXD101 is a potent,selective and orally active class I HDAC inhibitor with IC50s of 63 nM,570 nM and 550 nM for HDAC1,HDAC2 and HDAC3, respectively.CXD101 has no activity against HDAC class II.CXD101 has antitumor activity. | price> |
| R-R-3312 | S-14506 hydrochloride CAS No.286369-38-8 | S-14506 hydrochloride/CAS No.286369-38-8 is a potent 5-HT1A agonist, as well as 5-HT2A/2C antagonist. S-14506 hydrochloride displays dopamine antagonist properties by blocking dopamine D2 receptors. S-14506 hydrochloride inhibits the in vivo binding of [3H]raclopride in striatum and olfactory bulbs. S-14506 hydrochloride has the potential for the research of anxiolytic agent. | price> |
| R-C-1613 | Pluripotin (SC1) CAS:839707-37-8 | Pluripotin(SC1)is a dual inhibitor of extracellular signal-regulated kinase 1(ERK1,MAPK3)and RasGAP.Maintains embryonic stem cell(ESC)self-renewal.Pluripotin also inhibits RSK1,RSK2,RSK3 and RSK4 with IC50 of 0.5 µM,2.5 µM,3.3µM and 10.0µM,respectively. | price> |
| R-R-3313 | Amperozide CAS No.75558-90-6 | Amperozide/CAS No.75558-90-6 is an atypical antipsychotic that acts as an antagonist of the 5-HT2 receptor with a Ki value of 26 nM. Amperozide has a low affinity for D2 receptors. | price> |
| R-C-1614 | BMS309403 CAS:300657-03-8 | BMS-309403 is a potent,orally active and selective adipocyte fatty acid binding protein(also known as FABP4,aP2)inhibitor with Kis of <2,250,and 350 nM for FABP4,FABP3,and FABP5,respectively.BMS-309403 interacts with the fatty-acid-binding pocket within the interior of the protein and competitively inhibits the binding of endogenous fatty acids.BMS-309403 improves endothelial function in apolipoprotein E-deficient mice and in cultured human endothelial cells. | price> |
| R-R-3314 | BMY 14802 CAS No.105565-56-8 | BMY 14802/CAS No.105565-56-8 is a sigma-1 receptor (σ1R) antagonist, as well as an agonist at serotonin (5-HT) 1A and adrenergic alpha-1 receptors. | price> |
| R-C-1615 | SIS3 HCL CAS:521984-48-5 | SIS3 is a novel specific inhibitor of Smad3.It has effect on transforming growth factor-beta1-induced extracellular matrix expression. | price> |
| R-R-3315 | LY 165163 CAS No.1814-64-8 | LY 165163/CAS No.1814-64-8 is a potent 5-HT presynaptic receptor agonist. LY 165163 significantly decreases 5-HTP accumulation and increases DOPA accumulation in the cortex and striatum. | price> |
| R-C-1616 | A804598 CAS:1125758-85-1 | A-804598 is a CNS penetrant,competitive and selective P2X7 receptor antagonist with IC50s of 9 nM,10nM and 11 nM for mouse,rat and human P2X7 receptors, respectively. | price> |
| R-R-3316 | Iferanserin CAS No.58754-46-4 | Iferanserin (S-MPEC)/CAS No.58754-46-4 is a selective 5-HT receptor (serotonin receptor) antagonist with an affinity for 5-HT2A receptor. Iferanserin has the potential for internal hemorrhoid disease treatment. | price> |
| R-C-1617 | GW4869 CAS:6823-69-4 | GW4869(GW69A,GW554869A)is a neutral,noncompetitive inhibitor of sphingomyelinase (SMase)with an IC50 of 1μM.It is selective for N-SMase,and does not inhibit acid SMase at up to at least 15μM. | price> |
| R-R-3317 | Olanzapine-d3 CAS No.786686-79-1 | Olanzapine-d3/CAS No.786686-79-1 is the deuterium labeled Olanzapine. Olanzapine is a selective, orally active monoaminergic antagonist with high affinity binding to serotonin H1, 5HT2A/2C, 5HT3, 5HT6 (Ki=7, 4, 11, 57, and 5 nM, respectively), dopamine D1-4 (Ki=11 to 31 nM), muscarinic M1-5 (Ki=1.9-25 nM), and adrenergic α1 receptors (Ki=19 nM). Olanzapine is an atypical antipsychotic. | price> |

Items-$0.00

Email:
Tel.:
RuixiBiotechCo.Ltd /KamulinBiotechco.ltd
Add: Room 20F 2002, Meiyuan Building, Yanta District, Xi’ an City, Shaanxi Province 710061 China
Tel: 02988811435
Fax: (86-29)8881-1435
Email: sales@ruixibiotech.com
Web: http://www.ruixibiotech.com


